CEO Ian Mortimer buys $1.1 million of Xenon Pharmaceuticals Inc. (XENE)

About this page

WallStPal explains public SEC filings and congressional stock trade reports in plain English. Nothing is for sale; the site is free and supported by ads.

How to read it

Form 4

The form a company insider (officer, director or owner of more than 10%) must file with the SEC within two business days of buying or selling the company's shares.

13F

A quarterly list of U.S. stocks held by an investment manager with more than $100 million, filed within 45 days after each quarter ends.

STOCK Act

A 2012 law that requires members of Congress to report stock trades by themselves, a spouse or a dependent child within 45 days.

A real example

In January 2016, when bank stocks were falling, JPMorgan Chase CEO Jamie Dimon bought 500,000 JPMorgan shares with his own money, worth about $26 million. His Form 4 made the purchase public within days, and investors read it as a strong sign of confidence.

Explain it like I'm 13

We read the long, boring forms that grown-ups file with the government and tell you what they say in normal words.

Data from public SEC filings and congressional reports. Information, not investment advice. Check every number against the filing linked on the page.

CEO Ian Mortimer buys $1.1 million of Xenon Pharmaceuticals Inc. (XENE)

Ian Mortimer, chief executive, bought $1.1 million of stock. WallStPal Score 61.

WallStPal ScoreHow much this purchase says, from 0 to 100. How it works

Ian Mortimer, chief executive of Xenon Pharmaceuticals Inc., bought 30,000 shares on the open market on September 30, 2026 at an average of $37.38 a share, for a total of $1.1 million. The purchase was reported to the SEC on Form 4 on October 1, 2026.

It raised their holding by 151%, to 49,923 shares.

1 other insider also bought at least $10,000 of XENE within 30 days, which makes this a cluster buy.

In the 12 months up to this filing, Xenon Pharmaceuticals Inc. insiders reported 2 open-market purchases and 2 sales.

WallStPal Score: 61 out of 100, because of raised their holding by 151%; a large purchase; 1 other insider also bought; bought by a top executive.

It is too soon to say how the stock did afterward. This page will update as prices come in.

Source: SEC Form 4 filing ↗. This story was written automatically from the filing and weekly price data. Information, not investment advice.

Examples

Big insider purchases have made news before. In January 2016, with bank stocks falling, JPMorgan Chase CEO Jamie Dimon bought 500,000 JPMorgan shares, about $26 million of his own money, and the purchase was widely reported as a sign of confidence.

Explain it like I'm 13

Ian Mortimer helps run Xenon Pharmaceuticals Inc.. Spending $1.1 million of their own money on the company's stock is like a coach buying a big stack of tickets to their own team's games: it suggests they think the team will do well. It is not a promise, and insiders can be wrong.

More: all XENE insider trades · Ian Mortimer's track record